Israel Reports No Ebola Cases After Two Suspected Infections Test Negative
Israel's Health Ministry announced two individuals returning from the DRC tested negative for Ebola, maintaining the nation's record of no confirmed cases.
Health
Israeli Study Suggests Fat Loss ‘Memory’ Could Change How Doctors Treat Obesity
An Israeli study by Dr. Hadar Klein at Ben-Gurion University in Jerusalem reveals visceral fat loss creates a "memory," offering long-term health benefits even.
Move Transferring Activities of Two Psychiatric Hospitals to Other Facilities Expected to Improve Quality of Care
Israel's Health Ministry, Finance Ministry, and Israel Land Authority agreed to transfer psychiatric hospitals to general medical centers, investing $660.
‘Mental Iron Dome’: Yoga Linked to Higher Wartime Resilience Among Israeli Nurses
Prof. Meirav Ben-Natan's study at Hillel Yaffe Medical Center in Hadera links yoga to higher wartime resilience and lower stress among Israeli nurses.
RedHill Biopharma Drug Gets FDA Boost for Treating Childhood Cancer
RedHill Biopharma's investigational drug opaganib has received FDA rare pediatric disease designation for treating neuroblastoma in children.
Israeli Infant Receives First Gene Therapy for Rare Genetic Epilepsy
An 8-month-old infant in Israel received the first experimental gene therapy for rare WWOX-related epilepsy at Schneider Children's Hospital in Petah Tikva.
44 Israelis Hospitalized Since Renewal of Iranian Attacks
Since Iran's renewed attacks, 44 Israelis have been hospitalized, with one still in mild condition. The Health Ministry advises early preparation.
Israel Makes Preparations for Possible Ebola Outbreaks
Israel's Ministry of Health is proactively preparing for possible Ebola outbreaks by assessing its healthcare system and monitoring global developments.
7% of Older Israelis Are Visually Impaired
A recent survey shows 7% of older Israelis (65+) are visually impaired, a statistic impacting employment and financial stability.
Study Points to New Treatment Strategy for Prostate Cancer
An Israeli-led study by Prof. Yosef Yarden at the Weizmann Institute identifies a gene fusion mechanism causing prostate cancer resistance to standard hormone.